ID   MYO3A_HUMAN             Reviewed;        1616 AA.
AC   Q8NEV4; Q5VZ28; Q8WX17; Q9NYS8;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   02-NOV-2010, entry version 84.
DE   RecName: Full=Myosin-IIIa;
DE            EC=2.7.11.1;
GN   Name=MYO3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-1313.
RX   MEDLINE=20396137; PubMed=10936054; DOI=10.1006/geno.2000.6256;
RA   Dose A.C., Burnside B.;
RT   "Cloning and chromosomal localization of a human class III myosin.";
RL   Genomics 67:333-342(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT SER-1313, INVOLVEMENT IN DFNB30,
RP   AND FUNCTION.
RX   MEDLINE=22028976; PubMed=12032315; DOI=10.1073/pnas.102091699;
RA   Walsh T., Walsh V., Vreugde S., Hertzano R., Shahin H., Haika S.,
RA   Lee M.K., Kanaan M., King M.-C., Avraham K.B.;
RT   "From flies' eyes to our ears: mutations in a human class III myosin
RT   cause progressive nonsyndromic hearing loss DFNB30.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7518-7523(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1355, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-178; HIS-319; VAL-348; ILE-369;
RP   LYS-525; SER-833; ASN-956; ARG-956; THR-1032; MET-1045; MET-1137;
RP   ALA-1195; SER-1284; THR-1287; SER-1313; HIS-1347; ILE-1417 AND
RP   GLU-1488.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable actin-based motor with a protein kinase
CC       activity. Probably plays a role in vision and hearing.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- TISSUE SPECIFICITY: Strongest expression in retina, retinal
CC       pigment epithelial cells, cochlea and pancreas.
CC   -!- DISEASE: Defects in MYO3A are the cause of deafness autosomal
CC       recessive type 30 (DFNB30) [MIM:607101]. DFNB30 is a form of
CC       sensorineural hearing loss. Sensorineural deafness results from
CC       damage to the neural receptors of the inner ear, the nerve
CC       pathways to the brain, or the area of the brain that receives
CC       sound information.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein
CC       kinase superfamily. STE Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 3 IQ domains.
CC   -!- SIMILARITY: Contains 1 myosin head-like domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF229172; AAF70861.1; -; mRNA.
DR   EMBL; AY101367; AAM34500.1; -; mRNA.
DR   EMBL; AL162503; CAH73661.1; -; Genomic_DNA.
DR   EMBL; AL358612; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL391812; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL358612; CAH73814.1; -; Genomic_DNA.
DR   EMBL; AL162503; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL391812; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAD13206.2; -; Genomic_DNA.
DR   EMBL; AL391812; CAI17380.1; -; Genomic_DNA.
DR   EMBL; AL162503; CAI17380.1; JOINED; Genomic_DNA.
DR   EMBL; AL358612; CAI17380.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAI17380.1; JOINED; Genomic_DNA.
DR   IPI; IPI00185036; -.
DR   RefSeq; NP_059129.3; -.
DR   UniGene; Hs.662630; -.
DR   ProteinModelPortal; Q8NEV4; -.
DR   SMR; Q8NEV4; 336-1081.
DR   IntAct; Q8NEV4; 1.
DR   STRING; Q8NEV4; -.
DR   PhosphoSite; Q8NEV4; -.
DR   PRIDE; Q8NEV4; -.
DR   Ensembl; ENST00000265944; ENSP00000265944; ENSG00000095777.
DR   GeneID; 53904; -.
DR   KEGG; hsa:53904; -.
DR   NMPDR; fig|9606.3.peg.3667; -.
DR   UCSC; uc001isn.2; human.
DR   CTD; 53904; -.
DR   GeneCards; GC10P026263; -.
DR   H-InvDB; HIX0201520; -.
DR   HGNC; HGNC:7601; MYO3A.
DR   MIM; 606808; gene.
DR   MIM; 607101; phenotype.
DR   Orphanet; 90636; Autosomal recessive nonsyndromic sensorineural deafness type DFNB.
DR   PharmGKB; PA31405; -.
DR   HOGENOM; HBG314638; -.
DR   HOVERGEN; HBG052555; -.
DR   InParanoid; Q8NEV4; -.
DR   OMA; ATEHQID; -.
DR   OrthoDB; EOG9CRPJB; -.
DR   PhylomeDB; Q8NEV4; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 56212; -.
DR   ArrayExpress; Q8NEV4; -.
DR   Bgee; Q8NEV4; -.
DR   CleanEx; HS_MYO3A; -.
DR   Genevestigator; Q8NEV4; -.
DR   GermOnline; ENSG00000095777; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0031941; C:filamentous actin; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0060002; F:plus-end directed microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00612; IQ; 3.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 3.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50096; IQ; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Actin-binding; ATP-binding; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Deafness; Hearing; Kinase; Motor protein; Myosin;
KW   Non-syndromic deafness; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; Sensory transduction;
KW   Serine/threonine-protein kinase; Transferase; Vision.
FT   CHAIN         1   1616       Myosin-IIIa.
FT                                /FTId=PRO_0000086413.
FT   DOMAIN       21    287       Protein kinase.
FT   DOMAIN      340   1041       Myosin head-like.
FT   DOMAIN     1055   1084       IQ 1.
FT   DOMAIN     1082   1111       IQ 2.
FT   DOMAIN     1346   1375       IQ 3.
FT   NP_BIND      27     35       ATP (By similarity).
FT   ACT_SITE    150    150       Proton acceptor (By similarity).
FT   BINDING      50     50       ATP (By similarity).
FT   MOD_RES    1355   1355       Phosphoserine.
FT   VARIANT     178    178       T -> I (in dbSNP:rs33968748).
FT                                /FTId=VAR_040871.
FT   VARIANT     204    204       D -> N (in dbSNP:rs3737274).
FT                                /FTId=VAR_021866.
FT   VARIANT     319    319       R -> H (in dbSNP:rs3824700).
FT                                /FTId=VAR_040872.
FT   VARIANT     348    348       I -> V (in dbSNP:rs3824699).
FT                                /FTId=VAR_040873.
FT   VARIANT     369    369       V -> I (in dbSNP:rs3817420).
FT                                /FTId=VAR_040874.
FT   VARIANT     525    525       N -> K (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040875.
FT   VARIANT     833    833       A -> S (in dbSNP:rs33947968).
FT                                /FTId=VAR_040876.
FT   VARIANT     956    956       S -> N (in dbSNP:rs3758449).
FT                                /FTId=VAR_021867.
FT   VARIANT     956    956       S -> R (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040877.
FT   VARIANT    1032   1032       A -> T (in dbSNP:rs34918608).
FT                                /FTId=VAR_040878.
FT   VARIANT    1045   1045       V -> M (in dbSNP:rs35447806).
FT                                /FTId=VAR_040879.
FT   VARIANT    1137   1137       V -> M (in dbSNP:rs35449183).
FT                                /FTId=VAR_040880.
FT   VARIANT    1195   1195       V -> A (in dbSNP:rs35675577).
FT                                /FTId=VAR_040881.
FT   VARIANT    1284   1284       T -> S (in dbSNP:rs3740231).
FT                                /FTId=VAR_033905.
FT   VARIANT    1287   1287       P -> T (in dbSNP:rs35575696).
FT                                /FTId=VAR_040882.
FT   VARIANT    1313   1313       R -> S (in dbSNP:rs1999240).
FT                                /FTId=VAR_022779.
FT   VARIANT    1347   1347       D -> H (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040883.
FT   VARIANT    1417   1417       T -> I (in dbSNP:rs34151474).
FT                                /FTId=VAR_040884.
FT   VARIANT    1488   1488       K -> E (in dbSNP:rs34204285).
FT                                /FTId=VAR_040885.
FT   CONFLICT    418    418       M -> I (in Ref. 1 and 2).
FT   CONFLICT    636    636       A -> V (in Ref. 1 and 2).
FT   CONFLICT    848    851       RDTL -> KTLV (in Ref. 2; AAF70861).
FT   CONFLICT    886    890       TKNVI -> LKML (in Ref. 2; AAF70861).
FT   CONFLICT   1099   1099       R -> G (in Ref. 1 and 2).
FT   CONFLICT   1217   1217       S -> F (in Ref. 1 and 2).
FT   CONFLICT   1378   1378       R -> K (in Ref. 1 and 2).
SQ   SEQUENCE   1616 AA;  186208 MW;  7D126A7E22520574 CRC64;
     MFPLIGKTII FDNFPDPSDT WEITETIGKG TYGKVFKVLN KKNGQKAAVK ILDPIHDIDE
     EIEAEYNILK ALSDHPNVVR FYGIYFKKDK VNGDKLWLVL ELCSGGSVTD LVKGFLKRGE
     RMSEPLIAYI LHEALMGLQH LHNNKTIHRD VKGNNILLTT EGGVKLVDFG VSAQLTSTRH
     RRNTSVGTPF WMAPEVIACE QQLDTTYDAR CDTWSLGITA IELGDGDPPL ADLHPMRALF
     KIPRNPPPKL RQPELWSAEF NDFISKCLTK DYEKRPTVSE LLQHKFITQI EGKDVMLQKQ
     LTEFIGIHQC MGGTEKARRE RIHTKKGNFN RPLISNLKDV DDLATLEILD ENTVSEQLEK
     CYSRDQIYVY VGDILIALNP FQSLGLYSTK HSKLYIGSKR TASPPHIFAM ADLGYQSMIT
     YNSDQCIVIS GESGAGKTEN AHLLVQQLTV LGKANNRTLQ EKILQVNNLV EAFGNACTII
     NDNSSRFGKY LEMKFTSSGA VVGAQISEYL LEKSRVIHQA IGEKNFHIFY YIYAGLAEKK
     KLAHYKLPEN KPPRYLQNDH LRTVQDIMNN SFYKSQYELI EQCFKVIGFT MEQLGSIYSI
     LAAILNVGNI EFSSVATEHQ IDKSHISNHT ALENCASLLC IRADELQEAL TSHCVVTRGE
     TIIRPNTVEK ATDVRDAMAK TLYGRLFSWI VNCINSLLKH DSSPSGNGDE LSIGILDIFG
     FENFKKNSFE QLCINIANEQ IQYYYNQHVF AWEQNEYLNE DVDARVIEYE DNWPLLDMFL
     QKPMGLLSLL DEESRFPKAT DQTLVEKFEG NLKSQYFWRP KRMELSFGIH HYAGKVLYNA
     SGFLAKNRDT LPTDIVLLLR SSDNSVIRQL VNHPLTKTGN LPHSKTKNVI NYQMRTSEKL
     INLAKGDTGE ATRHARETTN MKTQTVASYF RYSLMDLLSK MVVGQPHFVR CIKPNSERQA
     RKYDKEKVLL QLRYTGILET ARIRRLGFSH RILFANFIKR YYLLCYKSSE EPRMSPDTCA
     TILEKAGLDN WALGKTKVFL KYYHVEQLNL MRKEAIDKLI LIQACVRAFL CSRRYQKIQE
     KRKESAIIIQ SAARGHLVRK QRKEIVDMKN TAVTTIQTSD QEFDYKKNFE NTRESFVKKQ
     AENAISANER FISAPNNKGS VSVVKTSTFK PEEETTNAVE SNNRVYQTPK KMNNVYEEEV
     KQEFYLVGPE VSPKQKSVKD LEENSNLRKV EKEEAMIQSY YQRYTEERNC EESKAAYLER
     KAISERPSYP VPWLAENETS FKKTLEPTLS QRSIYQNANS MEKEKKTSVV TQRAPICSQE
     EGRGRLRHET VKERQVEPVT QAQEEEDKAA VFIQSKYRGY KRRQQLRKDK MSSFKHQRIV
     TTPTEVARNT HNLYSYPTKH EEINNIKKKD NKDSKATSER EACGLAIFSK QISKLSEEYF
     ILQKKLNEMI LSQQLKSLYL GVSHHKPINR RVSSQQCLSG VCKGEEPKIL RPPRRPRKPK
     TLNNPEDSTY YYLLHKSIQE EKRRPRKDSQ GKLLDLEDFY YKEFLPSRSG PKEHSPSLRE
     RRPQQELQNQ CIKANERCWA AESPEKEEER EPAANPYDFR RLLRKTSQRR RLVQQS
//
